Table of Content


Introduction
Benign Prostatic Hyperplasia- Overview
Benign Prostatic Hyperplasia- Therapeutics Development
Benign Prostatic Hyperplasia- Therapeutics Assessment
Benign Prostatic Hyperplasia- Companies Involved in Therapeutics Development
Benign Prostatic Hyperplasia- Drug Profiles
Benign Prostatic Hyperplasia- Dormant Projects
Benign Prostatic Hyperplasia- Discontinued Products
Benign Prostatic Hyperplasia- Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Benign Prostatic Hyperplasia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Benign Prostatic Hyperplasia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Aiviva BioPharma Inc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Aphios Corp, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Aquestive Therapeutics Inc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by ASKA Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by BCWorld Pharm Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Chengdu Dikang Pharmaceuticals Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Curadis GmbH, H2 2020
Benign Prostatic Hyperplasia - Pipeline by DongKoo Bio & Pharma Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Dongkook Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Everon Biosciences Inc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by GemVax & KAEL Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Health Ever Bio-Tech Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Huons Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Kolmar Pharma Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Kwang Dong Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Mezzion Pharma Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Nymox Pharmaceutical Corp, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Ono Pharmaceutical Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Sophiris Bio Inc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by ValiRx Plc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by Veru Inc, H2 2020
Benign Prostatic Hyperplasia - Pipeline by XuanZhu Pharma Co Ltd, H2 2020
Benign Prostatic Hyperplasia - Dormant Projects, H2 2020
Benign Prostatic Hyperplasia - Dormant Projects, H2 2020 (Contd..1), H2 2020
Benign Prostatic Hyperplasia - Dormant Projects, H2 2020 (Contd..2), H2 2020
Benign Prostatic Hyperplasia - Discontinued Products, H2 2020